The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Joint Disease Therapeutics Market Research Report 2025
Synopsis
Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.
The global Joint Disease Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Joint Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Joint Disease Therapeutics.
Report Scope
The Joint Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Joint Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Joint Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Pfizer
Bristol-Myers Squibb
Roche
GlaxoSmithKline
AstraZeneca
Astellas Pharma
Johnson&Johnson
Amgen
Novartis
Sanofi
Daiiachi Sankyo
Segment by Type
Drug Therapy
Rehabilitation
Surgical Operation
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Joint Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Joint disease is defined as any type of injury or inflammation or disease that affects the joints of the body. Joint disease can range from acute to very chronic, excruciatingly painful or simply nagging and uncomfortable.
The global Joint Disease Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Joint Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Joint Disease Therapeutics.
Report Scope
The Joint Disease Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Joint Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Joint Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Pfizer
Bristol-Myers Squibb
Roche
GlaxoSmithKline
AstraZeneca
Astellas Pharma
Johnson&Johnson
Amgen
Novartis
Sanofi
Daiiachi Sankyo
Segment by Type
Drug Therapy
Rehabilitation
Surgical Operation
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Joint Disease Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Joint Disease Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug Therapy
1.2.3 Rehabilitation
1.2.4 Surgical Operation
1.3 Market by Application
1.3.1 Global Joint Disease Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Joint Disease Therapeutics Market Perspective (2019-2030)
2.2 Joint Disease Therapeutics Growth Trends by Region
2.2.1 Global Joint Disease Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Joint Disease Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Joint Disease Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Joint Disease Therapeutics Market Dynamics
2.3.1 Joint Disease Therapeutics Industry Trends
2.3.2 Joint Disease Therapeutics Market Drivers
2.3.3 Joint Disease Therapeutics Market Challenges
2.3.4 Joint Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Joint Disease Therapeutics Players by Revenue
3.1.1 Global Top Joint Disease Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Joint Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Joint Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Joint Disease Therapeutics Revenue
3.4 Global Joint Disease Therapeutics Market Concentration Ratio
3.4.1 Global Joint Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Joint Disease Therapeutics Revenue in 2023
3.5 Joint Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Joint Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Joint Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Joint Disease Therapeutics Breakdown Data by Type
4.1 Global Joint Disease Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Joint Disease Therapeutics Forecasted Market Size by Type (2025-2030)
5 Joint Disease Therapeutics Breakdown Data by Application
5.1 Global Joint Disease Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Joint Disease Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Joint Disease Therapeutics Market Size (2019-2030)
6.2 North America Joint Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Joint Disease Therapeutics Market Size by Country (2019-2024)
6.4 North America Joint Disease Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Joint Disease Therapeutics Market Size (2019-2030)
7.2 Europe Joint Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Joint Disease Therapeutics Market Size by Country (2019-2024)
7.4 Europe Joint Disease Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Joint Disease Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Joint Disease Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Joint Disease Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Joint Disease Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Joint Disease Therapeutics Market Size (2019-2030)
9.2 Latin America Joint Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Joint Disease Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Joint Disease Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Joint Disease Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Joint Disease Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Joint Disease Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Joint Disease Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Joint Disease Therapeutics Introduction
11.1.4 AbbVie Revenue in Joint Disease Therapeutics Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Joint Disease Therapeutics Introduction
11.2.4 Pfizer Revenue in Joint Disease Therapeutics Business (2019-2024)
11.2.5 Pfizer Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Joint Disease Therapeutics Introduction
11.3.4 Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2019-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Joint Disease Therapeutics Introduction
11.4.4 Roche Revenue in Joint Disease Therapeutics Business (2019-2024)
11.4.5 Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Joint Disease Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Joint Disease Therapeutics Introduction
11.6.4 AstraZeneca Revenue in Joint Disease Therapeutics Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Astellas Pharma
11.7.1 Astellas Pharma Company Detail
11.7.2 Astellas Pharma Business Overview
11.7.3 Astellas Pharma Joint Disease Therapeutics Introduction
11.7.4 Astellas Pharma Revenue in Joint Disease Therapeutics Business (2019-2024)
11.7.5 Astellas Pharma Recent Development
11.8 Johnson&Johnson
11.8.1 Johnson&Johnson Company Detail
11.8.2 Johnson&Johnson Business Overview
11.8.3 Johnson&Johnson Joint Disease Therapeutics Introduction
11.8.4 Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2019-2024)
11.8.5 Johnson&Johnson Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Joint Disease Therapeutics Introduction
11.9.4 Amgen Revenue in Joint Disease Therapeutics Business (2019-2024)
11.9.5 Amgen Recent Development
11.10 Novartis
11.10.1 Novartis Company Detail
11.10.2 Novartis Business Overview
11.10.3 Novartis Joint Disease Therapeutics Introduction
11.10.4 Novartis Revenue in Joint Disease Therapeutics Business (2019-2024)
11.10.5 Novartis Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Joint Disease Therapeutics Introduction
11.11.4 Sanofi Revenue in Joint Disease Therapeutics Business (2019-2024)
11.11.5 Sanofi Recent Development
11.12 Daiiachi Sankyo
11.12.1 Daiiachi Sankyo Company Detail
11.12.2 Daiiachi Sankyo Business Overview
11.12.3 Daiiachi Sankyo Joint Disease Therapeutics Introduction
11.12.4 Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2019-2024)
11.12.5 Daiiachi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Joint Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Drug Therapy
Table 3. Key Players of Rehabilitation
Table 4. Key Players of Surgical Operation
Table 5. Global Joint Disease Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Joint Disease Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Joint Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Joint Disease Therapeutics Market Share by Region (2019-2024)
Table 9. Global Joint Disease Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Joint Disease Therapeutics Market Share by Region (2025-2030)
Table 11. Joint Disease Therapeutics Market Trends
Table 12. Joint Disease Therapeutics Market Drivers
Table 13. Joint Disease Therapeutics Market Challenges
Table 14. Joint Disease Therapeutics Market Restraints
Table 15. Global Joint Disease Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Joint Disease Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Joint Disease Therapeutics as of 2023)
Table 18. Ranking of Global Top Joint Disease Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Joint Disease Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Joint Disease Therapeutics Product Solution and Service
Table 22. Date of Enter into Joint Disease Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Joint Disease Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Joint Disease Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Joint Disease Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Joint Disease Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Joint Disease Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Joint Disease Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Joint Disease Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Joint Disease Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Joint Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Joint Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Joint Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Joint Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Joint Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Joint Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Joint Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Joint Disease Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Joint Disease Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Joint Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Joint Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Joint Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Joint Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Joint Disease Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Joint Disease Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. AbbVie Company Detail
Table 48. AbbVie Business Overview
Table 49. AbbVie Joint Disease Therapeutics Product
Table 50. AbbVie Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 51. AbbVie Recent Development
Table 52. Pfizer Company Detail
Table 53. Pfizer Business Overview
Table 54. Pfizer Joint Disease Therapeutics Product
Table 55. Pfizer Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Pfizer Recent Development
Table 57. Bristol-Myers Squibb Company Detail
Table 58. Bristol-Myers Squibb Business Overview
Table 59. Bristol-Myers Squibb Joint Disease Therapeutics Product
Table 60. Bristol-Myers Squibb Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Bristol-Myers Squibb Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Joint Disease Therapeutics Product
Table 65. Roche Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Roche Recent Development
Table 67. GlaxoSmithKline Company Detail
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Joint Disease Therapeutics Product
Table 70. GlaxoSmithKline Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Development
Table 72. AstraZeneca Company Detail
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Joint Disease Therapeutics Product
Table 75. AstraZeneca Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Astellas Pharma Company Detail
Table 78. Astellas Pharma Business Overview
Table 79. Astellas Pharma Joint Disease Therapeutics Product
Table 80. Astellas Pharma Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 81. Astellas Pharma Recent Development
Table 82. Johnson&Johnson Company Detail
Table 83. Johnson&Johnson Business Overview
Table 84. Johnson&Johnson Joint Disease Therapeutics Product
Table 85. Johnson&Johnson Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Johnson&Johnson Recent Development
Table 87. Amgen Company Detail
Table 88. Amgen Business Overview
Table 89. Amgen Joint Disease Therapeutics Product
Table 90. Amgen Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 91. Amgen Recent Development
Table 92. Novartis Company Detail
Table 93. Novartis Business Overview
Table 94. Novartis Joint Disease Therapeutics Product
Table 95. Novartis Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Sanofi Company Detail
Table 98. Sanofi Business Overview
Table 99. Sanofi Joint Disease Therapeutics Product
Table 100. Sanofi Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 101. Sanofi Recent Development
Table 102. Daiiachi Sankyo Company Detail
Table 103. Daiiachi Sankyo Business Overview
Table 104. Daiiachi Sankyo Joint Disease Therapeutics Product
Table 105. Daiiachi Sankyo Revenue in Joint Disease Therapeutics Business (2019-2024) & (US$ Million)
Table 106. Daiiachi Sankyo Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Joint Disease Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Joint Disease Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Drug Therapy Features
Figure 4. Rehabilitation Features
Figure 5. Surgical Operation Features
Figure 6. Global Joint Disease Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Joint Disease Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Joint Disease Therapeutics Report Years Considered
Figure 12. Global Joint Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Joint Disease Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Joint Disease Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Joint Disease Therapeutics Market Share by Players in 2023
Figure 16. Global Top Joint Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Joint Disease Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Joint Disease Therapeutics Revenue in 2023
Figure 18. North America Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Joint Disease Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Joint Disease Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Joint Disease Therapeutics Market Share by Region (2019-2030)
Figure 32. China Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Joint Disease Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Joint Disease Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Joint Disease Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. AbbVie Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 47. Pfizer Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 51. AstraZeneca Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 52. Astellas Pharma Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 53. Johnson&Johnson Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 54. Amgen Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 55. Novartis Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 56. Sanofi Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 57. Daiiachi Sankyo Revenue Growth Rate in Joint Disease Therapeutics Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
